Farringdon Capital, Ltd. Haleon PLC Transaction History
Farringdon Capital, Ltd.
- $393 Billion
- Q3 2025
A detailed history of Farringdon Capital, Ltd. transactions in Haleon PLC stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 573,435 shares of HLN stock, worth $5.5 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
573,435
Previous 197,319
190.61%
Holding current value
$5.5 Million
Previous $2.05 Billion
151.38%
% of portfolio
1.31%
Previous 0.69%
Shares
2 transactions
Others Institutions Holding HLN
# of Institutions
684Shares Held
451MCall Options Held
114KPut Options Held
25.7K-
Dodge & Cox San Francisco, CA154MShares$1.48 Billion0.8% of portfolio
-
Clearbridge Investments, LLC New York, NY33.3MShares$320 Million0.24% of portfolio
-
Morgan Stanley New York, NY18.5MShares$178 Million0.01% of portfolio
-
Harding Loevner LP Bridgewater, NJ17.9MShares$172 Million1.22% of portfolio
-
Wellington Management Group LLP Boston, MA15.7MShares$150 Million0.03% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...